title: ACP Journal Club. In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
authors.forename: John R
authors.initials: JR
authors.lastname: Absher
mesh_terms: D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007252:Influenza Vaccines / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives*; D014611:Vaccination
chemical_list: D007166:Immunosuppressive Agents; D007252:Influenza Vaccines; D011409:Propylene Glycols; D013110:Sphingosine